Edition:
United States

Johnson Matthey PLC (JMAT.L)

JMAT.L on London Stock Exchange

3,061.00GBp
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
3,061.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
808,624
52-wk High
3,511.00
52-wk Low
2,677.68

Chart for

About

Johnson Matthey Plc is a specialty chemicals company. The Company operates in five divisions: Emission Control Technologies, which is a manufacturer of catalysts and catalyst systems for vehicles and industry; Process Technologies, which is a supplier of catalysts, licensing technologies and other services to the syngas,... (more)

Overall

Beta: 0.98
Market Cap(Mil.): £5,922.12
Shares Outstanding(Mil.): 193.53
Dividend: 21.75
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 26.44 15.71
EPS (TTM): -- -- --
ROI: -- 8.24 31.93
ROE: -- 10.68 16.16

BUZZ-Johnson Matthey falls after H1 results

** Johnson Matthey, a leader in catalysts for car emission control devices, slips 2.5 pct after first-half operating profit falls

Nov 21 2017

UPDATE 1-Johnson Matthey reports 2 pct fall in H1 operating profit

LONDON, Nov 21 Johnson Matthey, a leader in catalysts for car emission control devices, on Tuesday reported a 2 percent fall in first-half operating profit, following one-off charges related to restructuring.

Nov 21 2017

CORRECTED-Johnson Matthey to invest 200 mln pounds in battery material technology

LONDON, Sept 21 Johnson Matthey said it will invest an initial 200 million pounds ($270 mln) in expanding its battery material technology business from 2018, aiming to capitalise on growth in the electric vehicle market.

Sep 21 2017

Johnson Matthey to invest $200 mln in battery material technology

LONDON, Sept 21 Johnson Matthey said it will invest an initial $200 million in expanding its battery material technology business from 2018, aiming to capitalise on growth in the electric vehicle market.

Sep 21 2017

BRIEF-Nemaska Lithium receives final milestone payment from Johnson Matthey

* Nemaska Lithium receives final milestone payment from Johnson Matthey following approval of battery grade lithium hydroxide from phase 1 plant

Jul 26 2017

BRIEF-Intrexon, Johnson Matthey collaborate on production of peptide-based pharmaceutical ingredients

* Intrexon and Johnson Matthey collaborate on fermentative production of peptide-based active pharmaceutical ingredients

Jun 13 2017

Earnings vs. Estimates